Title:
SERPIN FUSION POLYPEPTIDE AND METHOD FOR USING THE SAME
Document Type and Number:
Japanese Patent JP2018008956
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a fusion protein comprising a molecule, in particular a polypeptide, more particularly an amino acid sequence derived from a serpin polypeptide or a serpin polypeptide and a second polypeptide.SOLUTION: According to the present invention, there is provided an isolated fusion protein comprising at least one human serpin polypeptide operably linked to a second polypeptide. Here, the second polypeptide comprises at least one the following: an immunoglobulin Fc polypeptide or an amino acid sequence that is derived from an immunoglobulin Fc polypeptide; a cytokine targeting polypeptide or a sequence derived from a cytokine targeting polypeptide; a WAP domain containing polypeptide or a sequence derived from a WAP domain containing polypeptide; or an albumin polypeptide or an amino acid sequence that is derived from a serum albumin polypeptide.SELECTED DRAWING: Figure 1A
Inventors:
BRENDAN P ECKELMAN
JOHN C TIMMER
PETER L NGUY
GRANT B GUENTHER
QUINN DEVERAUX
JOHN C TIMMER
PETER L NGUY
GRANT B GUENTHER
QUINN DEVERAUX
Application Number:
JP2017134043A
Publication Date:
January 18, 2018
Filing Date:
July 07, 2017
Export Citation:
Assignee:
INHIBRX LLC
International Classes:
C07K16/38; A61P31/12; C07K14/76; C07K14/765; C07K16/00; C07K19/00
Domestic Patent References:
JP2007504144A | 2007-03-01 | |||
JP2002537810A | 2002-11-12 | |||
JP2004537970A | 2004-12-24 | |||
JP2014519852A | 2014-08-21 |
Foreign References:
CA2758445A1 | 2010-10-28 |
Attorney, Agent or Firm:
Atsushi Aoki
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Tatsunori Ikeda
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Tatsunori Ikeda
Previous Patent: A pharmacological constituent, its manufacturing method, and the directions for a SHK base
Next Patent: Heterodimer immunoglobulin
Next Patent: Heterodimer immunoglobulin